|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-0.24/-0.22
|
企业价值
40.37M
|
资产负债 |
每股账面净值
0.20
|
现金流量 |
现金流量率
--
|
损益表 |
收益
2.90M
|
每股收益
0.12
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/04/30 20:12 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Dyadic International Inc is a world-wide biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology tothird parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1. |